BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 2891027)

  • 1. Relationship between alpha 2-adrenergic receptor binding sites and the functional receptors inhibiting norepinephrine release in rat cerebral cortex.
    Nasseri A; Minneman KP
    Mol Pharmacol; 1987 Nov; 32(5):655-62. PubMed ID: 2891027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor reserve at the alpha-2 adrenergic receptor in the rat cerebral cortex.
    Adler CH; Meller E; Goldstein M
    J Pharmacol Exp Ther; 1987 Feb; 240(2):508-15. PubMed ID: 3027315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of alpha-1 adrenergic receptors linked to [3H]inositol metabolism in rat cerebral cortex.
    Minneman KP; Johnson RD
    J Pharmacol Exp Ther; 1984 Aug; 230(2):317-23. PubMed ID: 6146710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that two stereochemically different alpha-2 adrenoceptors modulate norepinephrine release in rat cerebral cortex.
    Harsing LG; Vizi ES
    J Pharmacol Exp Ther; 1991 Jan; 256(1):44-9. PubMed ID: 1671099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding properties of alpha-1 adrenergic receptors in rat cerebral cortex: similarity to smooth muscle.
    Minneman KP
    J Pharmacol Exp Ther; 1983 Dec; 227(3):605-12. PubMed ID: 6140305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of the binding of the antihypertensive agent moxonidine to alpha 2-adrenoceptors in rat brain membranes.
    Ferry D; Armah BI; Goll A; Glossmann H
    Arzneimittelforschung; 1988 Oct; 38(10):1442-5. PubMed ID: 2848534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupancy of alpha 1-adrenergic receptors and contraction of rat vas deferens.
    Minneman KP; Fox AW; Abel PW
    Mol Pharmacol; 1983 Mar; 23(2):359-68. PubMed ID: 6300645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phorbol ester and staurosporine modulation of antagonist and agonist binding to alpha-2 adrenergic receptors: differential influence on Na+ versus guanylylnucleotide regulation.
    Jagadeesh G; Deth RC
    J Pharmacol Exp Ther; 1992 Aug; 262(2):775-83. PubMed ID: 1323662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Spare" alpha 1-adrenergic receptors and the potency of agonists in rat vas deferens.
    Minneman KP; Abel PW
    Mol Pharmacol; 1984 Jan; 25(1):56-63. PubMed ID: 6143249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occupancy-response relationships for beta- and alpha 2-adrenergic receptors exerting opposing effects on cAMP production.
    Atkinson BN; Minneman KP
    Receptor; 1992; 2(3):195-206. PubMed ID: 1361869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of agonist dissociation constants at central presynaptic alpha-2 autoreceptors in the absence of autoinhibition.
    Agneter E; Drobny H; Singer EA
    J Pharmacol Exp Ther; 1991 Apr; 257(1):19-25. PubMed ID: 1673473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-1 adrenergic receptor binding and contraction of rat caudal artery.
    Abel PW; Minneman KP
    J Pharmacol Exp Ther; 1986 Dec; 239(3):678-86. PubMed ID: 2879031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
    Hamblin MW; Ariani K; Adriaenssens PI; Ciaranello RD
    J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA; Davis KH; Titeler M
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain.
    Boyajian CL; Leslie FM
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1092-8. PubMed ID: 2885406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
    Convents A; De Backer JP; Convents D; Vauquelin G
    Mol Pharmacol; 1987 Jul; 32(1):65-72. PubMed ID: 2885739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.
    Neubig RR; Gantzos RD; Brasier RS
    Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does [3H]2-methoxy-idazoxan (RX 821002) detect more alpha-2-adrenoceptor agonist high-affinity sites than [3H]rauwolscine? A comparison of nine tissues and cell lines.
    Erdbrügger W; Raulf M; Otto T; Michel MC
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1287-94. PubMed ID: 7791100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further characterization of the presynaptic alpha-1 receptor modulating [3H]ACh release from rat atria.
    McDonough PM; Wetzel GT; Brown JH
    J Pharmacol Exp Ther; 1986 Aug; 238(2):612-7. PubMed ID: 2874215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 2-adrenergic receptors of the alpha 2c subtype mediate inhibition of norepinephrine release in human kidney cortex.
    Trendelenburg AU; Limberger N; Rump LC
    Mol Pharmacol; 1994 Jun; 45(6):1168-76. PubMed ID: 7912816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.